Antimicrobial peptides for combating drug-resistant bacterial infections

Jiaqi Xuan, Weiguo Feng, Jiaye Wang, Ruichen Wang, Bowen Zhang, Letao Bo, Zhe Sheng Chen, Hui Yang, Leming Sun

Research output: Contribution to journalReview articlepeer-review

334 Scopus citations

Abstract

The problem of drug resistance due to long-term use of antibiotics has been a concern for years. As this problem grows worse, infections caused by multiple bacteria are expanding rapidly and are extremely detrimental to human health. Antimicrobial peptides (AMPs) are a good alternative to current antimicrobials with potent antimicrobial activity and unique antimicrobial mechanisms, which have advantages over traditional antibiotics in fighting against drug-resistant bacterial infections. Currently, researchers have conducted clinical investigations on AMPs for drug-resistant bacterial infections while integrating new technologies in the development of AMPs, such as changing amino acid structure of AMPs and using different delivery methods for AMPs. This article introduces the basic properties of AMPs, deliberates the mechanism of drug resistance in bacteria and the therapeutic mechanism of AMPs. The current disadvantages and advances of AMPs in combating drug-resistant bacterial infections are also discussed. This article provides important insights into the research and clinical application of new AMPs for drug-resistant bacterial infections.

Original languageEnglish
Article number100954
JournalDrug Resistance Updates
Volume68
DOIs
StatePublished - May 2023

Keywords

  • Antibiotics
  • Antimicrobial peptides
  • Bacterial infection
  • Drug resistance

Fingerprint

Dive into the research topics of 'Antimicrobial peptides for combating drug-resistant bacterial infections'. Together they form a unique fingerprint.

Cite this